Cardiac allograft vasculopathy

From WikiMD.org
Jump to navigation Jump to search

Cardiac Allograft Vasculopathy (pronunciation: kahr-dee-ak al-uh-graft vas-kyuh-lop-uh-thee) is a medical condition that is often associated with Heart Transplantation.

Etymology

The term "Cardiac Allograft Vasculopathy" is derived from three words. "Cardiac" is derived from the Greek word "kardia" which means heart. "Allograft" is a term used in transplantation medicine to refer to a graft that comes from a donor of the same species but different genetic makeup. "Vasculopathy" is a general term for any disease of the blood vessels.

Definition

Cardiac Allograft Vasculopathy (CAV) is a form of Coronary Artery Disease that can occur in the transplanted heart. It is a major cause of morbidity and mortality in patients who have undergone a heart transplant.

Symptoms

The symptoms of Cardiac Allograft Vasculopathy are similar to those of other forms of coronary artery disease and may include chest pain, shortness of breath, fatigue, and heart failure. However, many patients with CAV do not experience symptoms until the disease is advanced.

Diagnosis

Diagnosis of Cardiac Allograft Vasculopathy is typically made through a combination of patient history, physical examination, and diagnostic tests such as Echocardiography, Coronary Angiography, and Intravascular Ultrasound.

Treatment

Treatment for Cardiac Allograft Vasculopathy may include medications to control risk factors such as high blood pressure and high cholesterol, as well as procedures to improve blood flow to the heart muscle such as Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski